Organic molecules for optoelectronic devices

Inhibitors of RET

BRD4-kinase inhibitors as cancer therapeutics

4-carboxamido-isoindolinone derivatives as selective parp-1 inhibitors

Hole transport material, manufacturing method thereof, and electroluminescent device thereof

Organic molecules for use in organic optoelectronic devices

Compounds for electronic devices

Pyrimidine Derivatives as Tropomyosin Receptor Kinase A (TRKA) Inhibitors

Pyrimidinone-containing compound, preparation method thereof, pharmaceutical composition and application thereof

Organic electroluminescent element and electronic device

Purine inhibitors of human phosphatidylinositol 3-kinase delta

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

Compounds and methods for the enhanced degradation of targeted proteins

Disubstituted pyrazole compounds

Antagonists of the muscarinic acetylcholine receptor M4

ANTIBODY-DRUG CONJUGATES AND RELATED COMPOUNDS, COMPOSITIONS AND METHODS

Purine inhibitors of human phosphatidylinositol 3-kinase delta

Oligomer of N,N′-di(hetero)aryl-5,10-dihydrophenazine, cathode active material, cathode, battery thereof, and process for preparing same

Organic molecules for use in optoelectronic devices

FUSED N-HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF

Carbocyclic prolinamide derivatives

Substituted pyrrolidine compound and use thereof

DERIVATIVES OF PIPERLONGUMINE AND USES THEREOF

SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS

Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors

SUBSTITUTED 4-(1-PYRROLIDINYL)PYRIMIDINE COMPOUNDS AS DIMERIZATION INHIBITORS OF NEURONAL NITRIC OXIDE SYNTHASE

Therapeutic compounds and methods of use thereof

(Hetero)arylamide compound for inhibiting protein kinase activity

Azulene ring-containing compound, its use, and an organic photoelectric device including the same

Alkylating agent for alkylating target with driver oncogene mutation

Compound, display panel and display apparatus

Heterocyclic compound, application thereof and pharmaceutical composition comprising same

Inhibitors of CaMKK2 and uses of same

Antagonists of the muscarinic acetylcholine receptor M

Double-labeled probe for molecular imaging and use thereof

Indole derivatives and use thereof

Inhibitors of human immunodeficiency virus replication

Pyridinone derivatives and their use as selective ALK-2 inhibitors

ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES

Detergents and cleaning agents having improved performance

INK SET AND INKJET RECORDING METHOD

Biocompatible modular tetrazine platform

Hsp90 inhibitors and uses thereof

Compounds and methods for targeting HSP90

Nitrogen-containing heterocycle and carbocycle derivatives having TrkA inhibitory activity

Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof

Modulators of THR-β and methods of use thereof

Pyrazole compounds and uses thereof

Double-labeled probe for molecular imaging and use thereof

Carbazole EHop-016 derivatives as anticancer and anti-migratory agents

Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases

Bioactive molecule conjugate, preparation method and use thereof

SOLID FORMS OF AN HIV PROTEASE INHIBITOR

Compound having cyclic structure

Substituted pyrrolidines as G-protein coupled receptor 43 agonists

Micro-electrolysis reactor for ultra fast, oxidant free, C—C coupling reaction and synthesis of daclatasvir analogs thereof

1,4-disubstituted pyridazine analogs thereof and methods for treating SMN-deficiency-related conditions

HIV protease inhibitors

Antagonists of the muscarinic acetylcholine receptor M

Thermally activated delayed fluorescent molecular material, method for synthesizing the same, and organic electroluminescent device

AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS

Organic electroluminescent materials and devices

Material for forming organic film, substrate for manufacturing semiconductor device, method for forming organic film, patterning process, and compound for forming organic film

Amide substituted indole compounds useful as TLR inhibitors

3-(5-amino-pyrazin-2-yl)-benzenesulfonamide derivatives and related compounds as PI3K-gamma kinase inhibitors

Organic molecules for use in optoelectronic devices

2,4-bis(nitrogen-containing group)-substituted pyrimidine compound, preparation method and use thereof

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

1-cyano-pyrrolidine derivatives as DUB inhibitors

Aminopyrimidinyl compounds

COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING MOTOR NEURON DISEASES

Heterocyclic amides useful as protein modulators

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

Quinazoline derivative or its salt and pharmaceutical composition comprising the same

Organic mixture and application thereof in organic electronic devices

PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF

AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND DERIVATIVES THEREOF

Branched Discrete PEG Constructs

DUAL FUNCTION MOLECULES FOR HISTONE DEACETYLASE INHIBITION AND ATAXIA TELANGIECTASIA MUTATED ACTIVATION AND METHODS OF USE THEREOF

(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases

Methods for Treating MS Using Pyrimidine and Pyridine Compounds with BTK Inhibitory Activity

Substituted triazole derivatives and uses thereof

Pharmaceutical compounds

Composition and organic light-emitting device including the same

Compounds as Ras Inhibitors and Use Thereof

Compounds and compositions as modulators of TLR signaling

Biguanide derivatives and their rearrangement products for use in the treatment of cancer

Heterocyclic compound and organic light emitting device comprising same

FUSED AND CROSS-LINKABLE IONIC HOLE TRANSPORT MATERIALS FOR PEROVSKITE SOLAR CELLS

Compound and organic light emitting device comprising same

Reaction medium containing water-surfactant mixture

Indolin-2-one derivatives

Piperazine derivatives as MAGL inhibitors

Organic electroluminescent compound and organic electroluminescent device comprising the same

Pyrrolidine derivative

Compositions for treating neurodegenerative diseases

ALLOSTERIC BCR-ABL PROTEOLYSIS TARGETING CHIMERIC COMPOUNDS

PCSK9 inhibitors and methods of use thereof

Benzimidazole derivatives, and pharmaceutical compositions and methods of use thereof

Organic electroluminescent materials and devices

Modulators of stimulator of interferon genes (STING)

Imidazole-pyrazole derivatives

BTK inhibitor compounds

METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY

Compositions of certain manganese accumulating plants

N-substituted indole derivatives as PGE2 receptor modulators

5-bromo-indirubins

High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging

SMAC mimetic

Metallo-beta-lactamase inhibitors and methods of use thereof

Compound, nanoribbon, and semiconductor device

Methods and compositions for modulating splicing

Substituted pyrimidine piperazine compound and use thereof

Heterocyclic compounds and uses thereof

Tetrazolinone compound and use thereof

Kinase inhibitors

DHFR INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO

Methods of inhibiting kinases

Pharmaceutical composition for preventing or treating acute myeloid leukemia or metastatic breast cancer

Compounds and their use for reducing uric acid levels

Composition for optoelectronic device and organic optoelectronic device and display device

Inhibitors of hepatitis C virus replication

Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders

Lanthionine synthetase C-like 2-based therapeutics

IDH1 INHIBITORS FOR THE TREATMENT OF HAEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS

Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same

INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF

Bi-heteroaryl substitute 1,4-benzodiazepines and uses thereof for the treatment of cancer

NLRX1 ligands

Amine substituted triazole derivatives and uses thereof

Materials for organic light emitting devices

Organic compound and organic electroluminescent device using the same

Methods and compositions for modulating splicing

Pharmaceutical composition derived from plant and a method for treating cancer

IL-17 ligands and uses thereof

Compound having ERK kinase inhibitory activity and use thereof

K-Ras modulators

Heterocyclic compound and organic light emitting device using same

ORGANIC LIGHT-EMITTING DEVICE

Dynamic control of colocalization of proteins

1,5-disubstituted 1,2,3-triazoles are inhibitors of Rac/Cdc42 GTPases

Tri-substituted imidazoles for the inhibition of TGF beta and methods of treatment

Inhibiting agents for Bruton's tyrosine kinase

Inhibitors of protein kinases

Organic electroluminescent materials and devices

Bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1H-1,3-benzodiazol-3-ium derivatives as ENaC inhibitors for treating respiratory diseases

EBNA1 inhibitors and methods using same

Organic molecules for use in optoelectronic devices

Ether compounds and uses thereof

Aryl substituted pyrimidines for use in influenza virus infection

Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors

Fluorene derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition comprising same as effective ingredient for preventing or treating HCV-related disease

Heterocyclic compounds as adenosine antagonists

Lysophosphatidic acid receptor 1 (LPAR1) inhibitor compounds

Inhibitors of lysine specific demethylase-1

Cyanopyrrolidines as dub inhibitors for the treatment of cancer

BIS-BIOTINYLATION TAGS

Methods and compositions for modulating splicing

SUBSTITUTED PYRROLIDINE AMIDES III

Organic molecules for optoelectronic devices

Bisamide sarcomere activating compounds and uses thereof

Bisamide sarcomere activating compounds and uses thereof

3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same

Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the same

Substituted 2-anilinopyrimidine derivatives as EGFR modulators

5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME

Composition for organic electronic devices

Dihydrobenzimidazolones for medical treatment

Pyrimidine derivative, method for preparing same and use thereof in medicine

DIMER COMPOUNDS, AND USE IN BINDING TOXIC REPEATS OF RNA

Heterocyclic inhibitors of PCSK9

Inhibitors of bruton's tyrosine kinase

Heterocyclic compound, composition including heterocyclic compound, and organic light-emitting device including heterocyclic compound

Compound and display panel containing the same

Compounds with an acceptor and a donor group

Organic light-emitting device and display apparatus including the same

RESIST UNDERLAYER FILM FORMING COMPOSITION CONTAINING COMPOUND HAVING HYDANTOIN RING

ORTHOGONAL GAMMA PNA DIMERIZATION DOMAINS EMPOWERING DNA BINDERS WITH COOPERATIVITY AND VERSATILITY MIMICKING THAT OF THE TRANSCRIPTION FACTOR PAIRS

Inhibitors of RHO associated coiled-coil containing protein kinase

Reactive oxygen species scavengers and use for treating diseases

Modulators of estrogen receptor proteolysis and associated methods of use

Syk inhibitor and use method therefor

Compounds and their use for reducing uric acid levels

Compound For Organic Electronic Element, Organic Electronic Element Using Same, And Electronic Device Thereof

Quinazoline compound for EGFR inhibition

Compound used as autophagy regulator, and preparation method therefor and uses thereof

HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

Quinolin-2-one derivatives

Quinolin-2-one derivatives

Biheteroaryl compounds and uses thereof

ORGANIC LIGHT-EMITTING DEVICE

2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof

EGFR inhibitor compounds

SUBSTITUTED 3-HETEROARYLOXY-1H-PYRAZOLES AND SALTS THEREOF AND THEIR USE AS HERBICIDAL ACTIVE SUBSTANCES

1-cyano-pyrrolidine compounds as USP30 inhibitors

CYCLOPROPYLAMINES AS LSD1 INHIBITORS

Condensed cyclic compound, composition including the same, and organic light-emitting device including thin film formed from the composition

Antifungal agents

Compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same

Sulfonamide-substituted cyanopyrrolidines with activity as DUB inhibitors

Compounds

Pharmaceutical compounds

Asymmetric triazole benzamide derivatives and the compositions and methods of treatment regarding the same

Certain chemical entities, compositions, and methods

Pharmaceutical compound

BIHETEROARYL COMPOUNDS AND USES THEREOF

Host materials for electroluminescent devices

Host materials for electroluminescent devices

Compound for organic electric element, organic electric element using the same, and electronic device thereof

Quinazoline and indole compounds to treat medical disorders

INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE AND HISTONE DEACETYLASE FOR TREATMENT OF CANCER

Compound and organic light-emitting device comprising same

KRAS G12C inhibitors and methods of using the same

3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof

2,4-bis(nitrogen-containing group)-substituted pyrimidine compound, preparation method and use thereof

Compounds, compositions, and methods for treating T-cell acute lymphoblastic leukemia

Crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1-yl)pyrimidin-4-amine and new salts

NON-INVASIVE VENTILATION WITH HIGH FREQUENCY OSCILLATIONS

Metallic salt containing anion having heterocyclic aromatic structure, method of preparing the metallic salt, and electrolyte and electrochemical device each including the metallic salt

Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof

Heterocyclic derivatives as PI3K inhibitors

Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors

Substituted heterocyclic derivatives as PI3K inhibitors

Substituted pyrrolidines as G-protein coupled receptor 43 agonists

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

Substituted indole Mcl-1 inhibitors

Hexamethylindanes

LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS

Compound, OLED display panel and electronic device

Heteroaryl pyrimidine compound and pest control agent

METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME

Pyrrolotriazine compounds as TAM inhibitors

Pyrazole derivatives for the treatment of cystic fibrosis

PYRAZOLYL QUINOXALINE KINASE INHIBITORS

FLUORESCENT PROBE FOR FLOW CYTOMETRY, AND METHOD FOR SCREENING FLUORESCENCE-LABELED CELLS

Pyridazinones as PARP7 inhibitors

Heterocyclic compound and organic light emitting element comprising same

ANTIVIRAL COMPOUNDS

Organic molecules for use in organic optoelectronic devices

Calpain modulators and therapeutic uses thereof

OLIGOMER AND LITHIUM BATTERY

Composition of matter for use in organic light-emitting diodes

COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES

Composition of matter for use in organic light-emitting diodes

Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS

Methods for treating Huntington's disease

Organic light emitting element and composition for organic material layer in organic light emitting element

DNA-PK inhibitors

6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors

Inhibitors of the fibroblast growth factor receptor

PKM2 modulators and methods for their use

INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR AND USE THEREOF

Inhibitors of lysine specific demethylase-1

Fused pyrimidine compounds as BRD4 and JAK2 dual inhibitors and methods for use thereof

Substituted phenazines and methods of treating cancer and bacterial diseases

4-aminoquinazolinyl compounds as prolyl hydroxylase inhibitors

Compounds for use in the treatment of kinetoplastid infection

Benzoimidazole derivatives as PAD4 inhibitors

NUCLEAR TRANSPORT MODULATORS AND USES THEREOF

Pyrazole MAGL inhibitors

Nitrogen-containing heterocycle and carbocycle derivatives having TrkA inhibitory activity

Quaternary amine compounds and antibody-drug conjugates thereof

Aminopyrimidine compound, preparation method therefor and use thereof

Pyrimidine derivative compound, optical isomer thereof, or pharmaceutically acceptable salt thereof, and composition for preventing or treating Tyro 3 related disease comprising same as active ingredient

Substituted benzoimidazoles and imidazo[4,5-c]pyridines for treating certain leukemias

2,4-pyrimidinediamine compounds and their uses

Thiobenzoimidazole as fungicides

HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE

(R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity

Composition of matter for use in organic light-emitting diodes

Nrf2 REGULATORS

Positive allosteric modulators of the muscarinic acetylcholine receptor M

SGC stimulators

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

Benzimidazole compounds and use thereof for treating Alzheimer's Disease or Huntington's Disease

Biaryl piperidine amide compounds and methods of use thereof

Selective NR2B antagonists

Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders

Poly-ADP ribose polymerase (PARP) inhibitors

HETEROCYCLIC COMPOUNDS AS HIV PROTEASE INHIBITORS

Arylquinazolines

Nitrogen-containing heterocycles for use in OLEDs

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

ANTI-CANCER STEMNESS DRUGS

Salts of IJAK inhibitors and methods of using the same

Methods for treating melanoma using small molecules

DNA-PK inhibitors

HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS

Substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereof

Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors

4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof

Bifunctional compounds

Toll-like receptor 9 antagonists

Compositions and methods for modulating protease activity

Heterocyclic compound and organic light-emitting device comprising same

Substituted 2-(het)arylimidazolylcarboxyamides as pesticides

PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulators